Dr. Afshar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5169 S Cottonwood St
Ste 520
Murray, UT 84107Phone+1 801-507-4701Fax+1 801-507-4811
Summary
- Clinical interests include hypertrophic cardiomyopathy, heart transplantation, mechanical circulatory support, and valvular heart disease.
Board certified in internal medicine, cardiovascular medicine, heart failure & transplantation, and echocardiography.
Currently act as the Director of the Hypertrophic Cardiomyopathy Center of Excellence at Intermountain Medical Center as well as Director of Heart Failure Services.
Education & Training
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2013 - 2014
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2009 - 2013
- Johns Hopkins UniversityChief Residency, Internal Medicine, 2010 - 2011
- Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
- University of Pittsburgh School of MedicineClass of 2006, Member of Alpha Omega Alpha (AOA), Member of Arnold P. Gold Humanism Honor Society, Peter Safar Memorial Award in Multidisciplinary Critical Care Medicine
- University of California, Los Angeles (UCLA)BS, Biochemistry, 1996 - 2001
Certifications & Licensure
- UT State Medical License 2014 - 2026
- ID State Medical License 2015 - 2025
- OH State Medical License 2009 - 2014
- MD State Medical License 2010 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 450 citationsMavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P. Abraham, Ahmad Masri
Lancet. 2020-09-12 - 23 citationsMixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observationsAbdallah G. Kfoury, Dylan V. Miller, Greg Snow, K. Afshar, Josef Stehlik
The Journal of Heart and Lung Transplantation. 2016-03-01 - 6 citationsDiscovery of TITIN Gene Truncating Variant Mutations and 5-Year Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.Jeffrey L. Anderson, G. Bryce Christensen, Helaman Escobar, Benjamin D. Horne, Stacey Knight
The American Journal of Cardiology. 2020-12-15
Books/Book Chapters
Press Mentions
- Murray Center Treating Rare Heart Condition Designated as One of a Kind in Intermountain WestAugust 6th, 2017
- Dr. Afshar's GridJune 2nd, 2015
Professional Memberships
- Member
- Member
- International Society of Heart & Lung Transplantation - ISHLTMember
- Society of Cardiac Magnetic Resonance Imaging - SCMRMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: